“The year has started on a strong note and we continue to be well-positioned for the remainder of 2021. We are working diligently preparing to close our merger with ICON, which is anticipated to close in July of this year.”
Read More
PRA Health Sciences on Wednesday morning announced financials that exceeded Wall Street expectations – and then disclosed it had been acquired in a $12 billion deal by Ireland-based ICON. As a result, Raleigh will lose a company headquarters.
Read More
PRA Health Sciences is in really good health rinancially right now, but looking ahead it warned on Wednesday that the pandemic clouds the future.
Read More
“Considering the very difficult circumstances, I was delighted with our second quarter financial results,” says Colin Shannon, PRA’s President and Chief Executive Officer.
Read More
Through a series of conversational questions and interactions, the company said per its release, the COVID-19 chatbot compares users’ symptoms to U.S. Centers for Disease Control guidance and then recommends one of three available COVID-19 programs in which they should enroll.
Read More
PRA Health Sciences, with headquarters in Raleigh, has expanded its Mobile Health Platform for remote clinical monitoring. The app-based platform allows sponsors to do everything that’s possible in a physician’s office or clinical site, virtually.
Read More
Symphony Health’s proprietary Synoma de-identification engine enables integration of complementary data sets from across the health ecosystem using a unique token. By working closely with Datavant, Symphony Health gives its customers the flexibility to connect data integrated via Synoma to the hundreds of unique data sets available through Datavant.
Read More
The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $1.48 per share.
Read More
PRA Health Sciences is working tohelp clinical trials go virtual. We’ve got the details.
Read More
